13F HOLDINGS REPORT
VR Adviser, LLC
Quarter ended Q1 2024 · Filed May 15, 2024 · Accession 0001104659-24-061948
Total Value
$2.10B
Positions
38
Other Managers
0
Confidential Omitted
No
Holdings (38)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | APOGEE THERAPEUTICS INC | APGE | 8,493,321 | $564.4M | 26.85% |
| 2 | 4D MOLECULAR THERAPEUTICS IN | FDMT | 4,400,000 | $140.2M | 6.67% |
| 3 | OCULAR THERAPEUTIX INC | OCUL | 12,762,462 | $116.1M | 5.52% |
| 4 | SPYRE THERAPEUTICS INC | SYRE | 2,171,782 | $82.4M | 3.92% |
| 5 | MERUS N V | N5749R100 | 1,790,214 | $80.6M | 3.83% |
| 6 | PHARVARIS N V | PHVS | 3,395,606 | $78.5M | 3.73% |
| 7 | KALVISTA PHARMACEUTICALS INC | KALV | 6,249,731 | $74.1M | 3.53% |
| 8 | ENLIVEN THERAPEUTICS INC | ELVN | 4,026,331 | $70.8M | 3.37% |
| 9 | VIRIDIAN THERAPEUTICS INC | VRDN | 3,882,671 | $68.0M | 3.23% |
| 10 | DIANTHUS THERAPEUTICS INC | DNTH | 2,094,373 | $62.8M | 2.99% |
| 11 | DYNE THERAPEUTICS INC | DYN | 2,173,913 | $61.7M | 2.94% |
| 12 | APPLIED THERAPEUTICS INC | 03828A101 | 9,075,000 | $61.7M | 2.94% |
| 13 | ORIC PHARMACEUTICALS INC | ORIC | 4,394,527 | $60.4M | 2.87% |
| 14 | ASTRIA THERAPEUTICS INC | 04635X102 | 3,608,645 | $50.8M | 2.42% |
| 15 | MERSANA THERAPEUTICS INC | 59045L106 | 11,328,000 | $50.7M | 2.41% |
| 16 | ENGENE HOLDINGS INC | ENGNW | 2,565,841 | $43.5M | 2.07% |
| 17 | PRAXIS PRECISION MEDICINES I | PRAX | 706,126 | $43.1M | 2.05% |
| 18 | HILLEVAX INC | 43157M102 | 2,075,000 | $34.5M | 1.64% |
| 19 | COGENT BIOSCIENCES INC | COGT | 5,129,167 | $34.5M | 1.64% |
| 20 | EDGEWISE THERAPEUTICS INC | EWTX | 1,818,182 | $33.2M | 1.58% |
| 21 | CABALETTA BIO INC | CABA | 1,563,952 | $26.7M | 1.27% |
| 22 | ARVINAS INC | ARVN | 627,788 | $25.9M | 1.23% |
| 23 | TAYSHA GENE THERAPIES INC | TSHA | 9,000,000 | $25.8M | 1.23% |
| 24 | AQUESTIVE THERAPEUTICS INC | AQST | 5,555,555 | $23.7M | 1.13% |
| 25 | TERNS PHARMACEUTICALS INC | TERN | 3,410,058 | $22.4M | 1.06% |
| 26 | ADVERUM BIOTECHNOLOGIES INC | 00773U207 | 1,556,419 | $22.0M | 1.05% |
| 27 | CELCUITY INC | CELC | 970,000 | $21.0M | 1.00% |
| 28 | ABIVAX SA | AAVXF | 1,345,780 | $19.2M | 0.92% |
| 29 | IMMATICS N.V | IMTX | 1,750,000 | $18.4M | 0.87% |
| 30 | LYRA THERAPEUTICS INC | LYRA | 2,576,093 | $16.0M | 0.76% |
| 31 | CG ONCOLOGY INC | CGON | 350,000 | $15.4M | 0.73% |
| 32 | CENTURY THERAPEUTICS INC | IPSC | 3,405,133 | $14.2M | 0.68% |
| 33 | TREVI THERAPEUTICS INC | TRVI | 3,422,675 | $11.8M | 0.56% |
| 34 | TENAYA THERAPEUTICS INC | TNYA | 1,555,556 | $8.1M | 0.39% |
| 35 | MINERALYS THERAPEUTICS INC | MLYS | 555,554 | $7.2M | 0.34% |
| 36 | ACELYRIN INC | 00445A100 | 937,113 | $6.3M | 0.30% |
| 37 | EYEPOINT PHARMACEUTICALS INC | EYPT | 250,000 | $5.2M | 0.25% |
| 38 | OLEMA PHARMACEUTICALS INC | OLMA | 77,042 | $872,115 | 0.04% |